Technical information
Manufacturer
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Presentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
xXsmPPZCvapgY6Vd